Geode Capital Management, LLC Anavex Life Sciences Corp. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,831,253 shares of AVXL stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,831,253
Previous 1,712,727
6.92%
Holding current value
$10.4 Million
Previous $8.72 Million
11.36%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AVXL
# of Institutions
152Shares Held
26.5MCall Options Held
674KPut Options Held
811K-
Black Rock Inc. New York, NY6.39MShares$36.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.55MShares$25.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$21.2 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.01MShares$5.75 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL669KShares$3.8 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $443M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...